EVENT POSTPONED DUE TO COVID-19
To safeguard against COVID-19, we have taken the decision to postpone this event. We are working with the venue to schedule a new date later this year.
Register your interest here to receive updates.
Exploring the value of theragnostic radionuclide therapies within advanced oncology
Inspired by the reinvigoration the field has seen over the last 2 years, the Targeted Radiopharmaceuticals (TRP) Summit is the primary platform for industry-led discussion of the challenges and opportunities facing developers of theranostic radio ligand therapies.
Following the hugely successful meeting of key opinion leaders in 2019, this conference returns with a wider array of insights from recent case studies to help you accelerate the development of the next-generation of radioligand therapies from clinical approval to commercialisation.